Sex difference in resistance to dexamethasone-induced apoptosis in NOD mice: Treatment with 1,25(OH)2D3 restores defect

Diabetes

Volumn 47, Issue 7, 1998, Pages 1033-1037

  Casteels, Kristina M ^a   Gysemans, Constantia A ^a   Waer, Mark ^a   Bouillon, Roger ^a   Laureys, Jos M ^a   Depovere, Jos ^a   Mathieu, Chantal ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b LEGENDO   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; DEXAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; EFFECTOR CELL; FLUORESCENCE ACTIVATED CELL SORTER; HORMONE RESISTANCE; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; THYMOCYTE;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; CALCITRIOL; DEXAMETHASONE; DIABETES MELLITUS, TYPE 1; DIHYDROTESTOSTERONE; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; LYMPHOCYTE COUNT; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; ORCHIECTOMY; SEX CHARACTERISTICS; THYMUS GLAND;

EID: 0031747106     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.7.1033     Document Type: Article

References (30)

1. Mountz J, Wu J, Cheng J, Zhou T: Autoimmune disease: a problem of defective apoptosis. Arthritis Rheum 37:1415-1420, 1994
2. Watanabe-Fukunaga R, Brannan C, Copeland N, Jenkins N, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317, 1992
3. Takahashi T, Tamaka M, Brannan C, Jenkins N, Copeland N, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976, 1994
4. McDonnel T, Deane N, Platt F, Nunez G, Jaeger U, McKearn J, Korsmeyer S: Bcl-2-immimoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation. Cell 57:79-88, 1989
5. Strasser A, Whittingham S, Vaux D, Bath M, Adams J, Cory S, Harris H: Enforced bcl-2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc Natl Acad Sci USA 88:8861-8865, 1991
6. Strasser A, Harris A, Cory S: Bcl-2 transgene inhibits T-cell death and perturbs thymic self-censorship. Cell 67:889-899, 1991
7. Sentman C, Shutter J, Hockenbery D, Kanagawa O, Korsmeyer S: Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell 67:879-888, 1991
8. Cohen J, Duke R, Fadok V, Sellins K: Apoptosis and programmed cell death in immunity. Immunol Rev 10:267-293, 1992
9. Garchon H, Luan J, Eloy L, Bédossa P, Bach JF: Genetic analysis of immune dysfunction in NOD mice: mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T-cells to apoptosis induction. Eur J Immunol 24:380-384, 1994
10. Leijon K, Hammarström B, Holmberg D: NOD mice display enhanced immune responses and prolonged survival of lymphoid cells. Int Immunol 6:339-345, 1994
11. Penha-Goncalves C, Leijon on K, Persson L, Holmberg D: Type I diabetes and the control of dexamethasone-induced apoptosis in mice maps to the same region on chromosome 6. Genomics 28:398-404, 1995
12. Colucci F, Cilio C, Leyon K, Penha-Goncalves C, Bergman M, Holmberg D: Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide. J Autoimmun 9:271-276, 1996
13. Colucci F, Bergman M, Penha-Goncalves C, Cilio C, Holmberg D: Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to Idd5 diabetes susceptibility region. Proc Natl Acad Sci USA 94:8670-8674, 1997
14. Lampeter E, Signore A, Gale E, Pozzilli P: Lessons from the NOD mouse for the pathogenesis and Immunotherapy of human type T (insulin-dependent) diabetes mellitus. Diabetologia 32:703-708, 1989
15. Makino S, Kunimoto K, Muraoka Y, Katagiri K: Effect of castration on the appearance of diabetes in NOD mouse. Exp Anim 30:137-140, 1981
16. Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez E, Bach J, Dardenne M: Sex steroids, glucocorticoids, stress and autoimmunity J Steroid Biochem Molec Biol 40:619-637, 1991
17. Fox H: Androgen treatment prevents diabetes in nonobese diabetic mice. J Exp Med 175:1409-1412, 1992
18. Fitzpatrick F, Lepault F, Homo-Delarche F, Bach J, Dardenne M: Influence of castration, alone or combined with thymectomy, on the development of diabetes ill the nonobese diabetic mouse. Endocrinology 129:1382-1390, 1991
19. Hawkins T, Gala R, Dunbar J: The effect of neonatal sex hormone manipulation on the incidence of diabetes in nonobese diabetic mice. Proc Soc Exp Biol Med 40:619-637, 1993
20. Kovacs WJ, Olsen NJ: Androgens receptors in human thymocytes. J Immunol 139:490-493, 1987
21. Danel L, Menouni M, Cohen HM, Magaud JP, Lenoir G, Revillard JP, Saez S: Distribution of androgen and estrogen receptors among lymphoid and haemopoietic cell lines. Leuk Res 9:1373-1378, 1985
22. 3prevents insulitis in NOD mice. Diabetes 41:1491-1495, 1992
23. 3. Diabetologia 37:552-558, 1994
24. 3, KH1060. Endocrinology 136:866-872, 1995
25. 3 in combination with a short induction course of cyclosporin A. Endocrinology 139:96-102, 1998
26. 3 restores sensitivity to cyclophosphamide-induced apoptosis in NOD mice and protects against diabetes. Clin Exp Immunol 112:181-187, 1998
27. Pozzilli P, Signore A, Williams AJ, Beales P: NOD mouse colonies around the world: recent facts and figures. Immunol Today 14:193-196, 1993
28. Serreze D, Gaskins HR, Leiter E: Defects in the differentiation and function of antigen-presenting cells in NOD/lt mice. J Immunol 150:2534-2543, 1993
29. James S, Mackay A, Colston K: Vitamin D derivatives in combination with 9-cis-retinoic acid promote active cell death in breast cancer cells. J Mol Endocrinol 14:391-394, 1995
30. Korsmeyer S: Bcl-2: a repressor of lymphocyte death. Immunol Today 13:285-287, 1992